Combination CTLA4Ig and Anti-CD40 Ligand Treatment Modifies T and B Cell Metabolic Profiles and Promotes B Cell Receptor Remodeling in a Mouse Model of Systemic Lupus Erythematosus
Chirag Raparia, Tam D. Quach, Leilani Zeumer-Spataro, Seung Chul Choi, Zhengzi Yi, Weijia Zhang, Laurence Morel, Anne Davidson
Profundice en los temas de investigación de 'Combination CTLA4Ig and Anti-CD40 Ligand Treatment Modifies T and B Cell Metabolic Profiles and Promotes B Cell Receptor Remodeling in a Mouse Model of Systemic Lupus Erythematosus'. En conjunto forman una huella única.